SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-17-004696
Filing Date
2017-07-20
Accepted
2017-07-20 16:02:28
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B4 a2232720z424b4.htm 424B4 2522916
2 G55359.JPG g55359.jpg GRAPHIC 17412
3 G938014.JPG g938014.jpg GRAPHIC 83133
4 G1033250.JPG g1033250.jpg GRAPHIC 88988
5 G18119.JPG g18119.jpg GRAPHIC 131779
6 G241059.JPG g241059.jpg GRAPHIC 113914
7 G496397.JPG g496397.jpg GRAPHIC 35488
8 G159140.JPG g159140.jpg GRAPHIC 33443
9 G307031.JPG g307031.jpg GRAPHIC 40048
10 G1043971.JPG g1043971.jpg GRAPHIC 18166
11 G64689.JPG g64689.jpg GRAPHIC 69981
12 G943318.JPG g943318.jpg GRAPHIC 64315
13 G171109.JPG g171109.jpg GRAPHIC 57409
14 G327688.JPG g327688.jpg GRAPHIC 24839
15 G163449.JPG g163449.jpg GRAPHIC 16765
16 G569389.JPG g569389.jpg GRAPHIC 89929
  Complete submission text file 0001047469-17-004696.txt   3745701
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-218936 | Film No.: 17974392
SIC: 2834 Pharmaceutical Preparations